Quintiles touts Internet for patient recruitment; Agere boosts its manufacturing capabilities;

> Quintiles is celebrating new study data it says confirms the validity of using the Internet to recruit patients for clinical trials. More

> CMO Agere Pharmaceuticals has expanded its Phase IIb manufacturing capabilities, extending its spray-drying capabilities. News

> Agility Clinical is targeting small and virtual biotechs with its new strategic and operating consulting services, in addition to its CRO offerings. Item

> Novartis ($NVS) says its recently announced plans to build a manufacturing plant in Singapore will not effect its deal with CMO Lonza. Article

> Boehringer Ingelheim has struck a deal to manufacture E. coli and other highly potent materials for Molecular Partners' clinical trials. Story

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.